AstraZeneca dans l'actualité
Innovation en santé par la science
Tamtam a trouvé 16 articles récents sur AstraZeneca.
- AstraZeneca cuts ribbon on new R&D facility in Massachusetts
- AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos
- AstraZeneca CEO Soriot says drugmaker can grow without big acquisition
- How AstraZeneca is using robots to conduct science at new $1 billion Cambridge research center
- AstraZeneca opens new global strategic R&D centre in Kendall Square, Cambridge, Massachusetts
- AstraZeneca opens $1 billion R&D center in Kendall Square
- AstraZeneca to invest over $1 billion in Massachusetts, boost workforce
- Astra Doesn’t Need a Deal for Growth Beyond 2030, CEO Says
- ‘We’re here at the party now:’ AstraZeneca opens new Kendall hub with big hiring plans
- AstraZeneca completes equity investment in Summit Therapeutics
- IN BRIEF: AstraZeneca completes USD2 billion Summit investment
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- AstraZeneca Stocks Drops as $2 Billion Buys an Oncology Option
- AstraZeneca and two partners plan to test a cancer-drug pairing in breast cancer
- AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types
- Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme AstraZeneca ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires